Global Zebrafish For Research Market Is Expected To Reach Revenue Of USD 412.8 Mn By 2033, At 14.8% CAGR: Dimension Market Research.

(MENAFN- GlobeNewsWire - Nasdaq) Advancements and Projections in the Global Zebrafish for Research Market: Insights, Trends, Opportunities, and Recent Developments

New York, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Overview

The Global Zebrafish for Research market is projected to reach USD 118.8 million in 2024 which is further anticipated to reach USD 412.8 million by 2033 at a CAGR of 14.8%.

The global zebrafish for research market is growing rapidly, owing to its importance as a model organism in genetics, developmental biology, drug discovery, and toxicity testing because of its high genetic similarity to humans, with transparent embryos quite convenient to observe. Major regions of participation and intensive R&D activity are giving much strength to North America and Europe, while Asia-Pacific is expected to emerge with expanding investments.

Key players make use of innovation for growth based on emergent trends, including CRISPR gene editing and high-throughput screening. Key challenges include poor complex human physiological modeling and poor standardization of protocols, but zebrafish are key to several different research applications.

Click to Request Sample Report and Drive Impactful Decisions:

The US Zebrafish for Research Market

The US Zebrafish for Research Market with an estimated value of USD 35.1 million in 2024 is projected to increase at a compound annual growth rate of 13.9% until reaching USD 113.0 million by 2033.

The U.S. zebrafish research market will continue to grow with the increasing demand for affordable preclinical models in drug efficacy and toxicity testing is propelled by high government and private funding in the field. Indeed, the use of zebrafish is increasingly used in toxicity testing in pharmaceuticals and cosmetics due to regulatory pressures.

In addition to that, screening in large-scale trials of drug development at high throughput becomes increasingly common. Large players like Pentair, InVivo Biosystems, and Bioreperia develop new arbitrary zebrafish services, which further accelerates competitive dynamics. The leading position of the US market is expected to persist due to state-of-the-art research infrastructure and an ever-widening array of zebrafish applications in biomedical research.

Important Insights

• Global Market Share: The Global Zebrafish for Research Market is estimated at USD 118.8 million in 2024, projected to reach USD 412.8 million by 2033, driven by research expansion.
• The US Market Share : Expected at USD 35.1 million in 2024, the U.S. zebrafish market is forecasted to grow to USD 113.0 million by 2033 at a 13.9% CAGR.
• Regional Analysis: Asia Pacific is anticipated to hold the largest share in the Global Zebrafish for Research Market, approximately 44.3% in 2024, due to growing research investments.
• Key Players: Major players include Aquaneering Inc., Pentair PLC, Envigo RMS LLC, Charles River Laboratories, Danio Lab, ZeClinics, Techniplast, and Cyagen Biosciences, contributing to market development.
• Global Market Growth Rate : The zebrafish research market is anticipated to grow at a 14.8% CAGR over the forecast period, driven by increasing biotechnological research demand.

Latest Trends

• Adoption of Genetic Tools: Zebrafish, through CRISPR and other genetic editing tools, offer an avenue whereby many human disease mutations, especially cancer, neurodegenerative disorders, and cardiovascular conditions, can be modeled by mimicking human biology.
• Rise of High-Throughput Screening: Zebrafish are amenable to high-throughput drug screening due to their small size, rapid development, and close genetic relatedness to humans. Thus, high-speed large-scale compound testing can be enabled at significantly lower costs compared to mammalian models.

Zebrafish for Research Market: Competitive Landscape

• The global market for research in zebrafish is very competitive; the presence of key players such as Aquaneering Inc., Pentair PLC, and ZeClinics is also claiming developments in zebrafish systems and their respective services.
• While companies like Shanghai Model Organisms Center and Invivo Biosystems participate in genetic studies, a lot of value addition to the knowledge about diseases is made. Strategic collaborations, mergers, and partnerships with research-oriented academic institutes and pharmaceutical entities will drive innovation and facilitate access to superior genetic models and data.
• With new entrants like BioReperia and YSY Biotech targeting applications related to environmental toxicology, the market remains vibrant due to further product development and market reach through improvement in automation and CRISPR technologies.

Some of the prominent market players:

• Aquaneering Inc.
• Pentair PLC
• Envigo RMS LLC
• Charles River Laboratories
• Danio Lab
• ZeClinics
• Union Biometrica, Inc.
• Techniplast
• Cyagen Biosciences
• InVivo Biosystems
• ZFBioLabs
• Sinnhuber Aquatic Research Laboratory
• Other Key Players

Transform your business approach with strategic insights from our report. Get in touch to request our brochure today at

Zebrafish for Research Market Scope

Report Highlights	Details
Market Size (2024)	USD 118.8 Mn
Forecast Value (2033)	USD 412.8 Mn
CAGR (2024-2033)	14.8%
The US Market Size (2024)	USD 35.1 Mn
Asia Pacific Revenue Share (2024)	44.3%
Historical Data	2018 - 2023
Forecast Data	2024 - 2033
Base Year	2023
Estimate Year	2024
Segments Covered	Product Type, By Type, By Application
Regional Coverage	North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)

Market Analysis

Adult zebrafish are projected to dominate the product type segment of the global zebrafish research market with 36.0% in 2024 due to their developed physiology, which essentially comes closer to human biology. The presence of their fully developed systems enables research on several aspects related to neurobiology, drug discovery, and chronic toxicity, having reliable data over long-term exposure. This growing regulatory attention toward non-mammalian models during preclinical testing further boosts the demand for adult zebrafish, as they are considered to offer considerably predictive insights into human drug efficacy and safety. Therefore, adult zebrafish will continue their dominance, with growing applications in diversified fields, and are expected to continue further during the forecast period.

Zebrafish for Research Market Segmentation

By Product Type

• Adult Zebrafish
• Eggs/Embryos
• Larvae
• Transgenic Zebrafish

By Type

• Toxicity Testing
• Transgenesis and Gene Editing
• Disease Modeling
• Regenerative Medicine
• Developmental Biology
• Genetic Studies

By Application

• Pharmaceuticals
• Biotechnology
• Chemicals
• Cosmetics
• Environmental Monitoring
• Academic Research
• Others

Purchase the Competition Analysis Dashboard Today at

Growth Drivers

• Cost-Effectiveness: As a result of their inexpensive husbandry, rapid breeding, and high number of offspring, experiments performed in zebrafish are affordable models of high-throughput testing of drugs. The reasoning behind this attracts pharmaceutical companies and biotech to reduce preclinical testing costs.
• Ethical and Regulatory Support: Zebrafish are afforded regulatory support due to less ethical controversy in testing; promoted by the OECD toxicity testing protocols and increasing restrictions on traditional animal models.

Restraints

• Technical Limitations: The only limitation is that zebrafish have a poor capacity to model complicated human diseases, which require higher-order mammalian physiology. Thus, additional models are needed during the later stages that give specific insights.
• Competition from Alternative Models: Organoids now tend to compete with zebrafish by offering detailed human tissue insight using 3D cell culture and computational models. These are those areas of research that surround specific diseases and drugs where zebrafish models lack specificity.

Growth Opportunities

• Expansion in Asia-Pacific: Increased government investment for research in biotech increases demand for Zebrafish in local institutes and international collaborations of research, particularly in the Asia-Pacific region, driven by countries such as China, Japan, and India.
• Emerging Applications in Environmental Monitoring: Delicate embryos of zebrafish are used as significant models in environmental monitoring. They contribute to meeting the strict regulations on water quality and detecting contamination by heavy metals, pesticides, and other contaminants.

Click to Request Sample Report and Drive Impactful Decisions at

Regional Analysis

With significant funding related to biotechnology, the growing infrastructure of research, as well as friendly government policies, the Asia Pacific accounts for a regional share of 44.3% in the zebrafish research market in 2024. Major institutions in China, Japan, and Korea will continue with zebrafish research for drug discovery and genetic studies.

In addition, low-priced operations with a richly trained labor force and large health demands have been luring several partnerships availed globally, thus strengthening the position of the region. Government initiatives in countries like China further drive innovation, creating a robust ecosystem for biopharmaceuticals. Therefore, with the increasing number of publications and patents, the regional share of Asia-Pacific is expected to continue dominating the zebrafish research market during the forecast period.

By Region

North America

• The U.S.
• Canada

Europe

• Germany
• The U.K.
• France
• Italy
• Russia
• Spain
• Benelux
• Nordic
• Rest of Europe

Asia-Pacific

• China
• Japan
• South Korea
• India
• ANZ
• ASEAN
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America

Middle East & Africa

• Saudi Arabia
• UAE
• South Africa
• Israel
• Egypt
• Rest of MEA

Recent Developments in the Zebrafish for Research Market

• October 2024: Shanghai Model Organisms Center launched transgenic zebrafish models for neurodegenerative disease research, enhancing zebrafish's utility in studying complex human neurological disorders.
• August 2024: ZeClinics partnered with a major pharmaceutical company for high-throughput zebrafish-based toxicity testing, improving efficiency in novel drug candidate screening.
• June 2024: InVivo Biosystems expanded its services to include CRISPR gene-editing for creating customized zebrafish models, catering to specific research needs.
• December 2023: BioReperia introduced automated zebrafish screening solutions, accelerating toxicity testing processes and enhancing preclinical drug development efficiency.
• September 2023: Pentair PLC acquired a leading zebrafish system manufacturer, strengthening its research portfolio and supporting zebrafish-based research applications.
• July 2023: Aquaneering Inc. launched a next-generation zebrafish housing system with improved water quality monitoring, fostering healthier research environments for zebrafish models.
• April 2023: Techniplast partnered with European universities for zebrafish-based environmental research, focusing on innovative water quality monitoring techniques.

Discover additional reports tailored to your industry needs.

The Global Food Safety Testing Market is expected to reach a value of USD 23.7 billion in 2023, and it is further anticipated to reach a market value of USD 47.8 billion by 2032 at a CAGR of 8.1% .

The Global Food Additives Market is expected to be valued USD 143.5 billion in 2024 and is anticipated to reach USD 242.9 billion by 2033 at a CAGR of 6.0%.

The Global Bakery Product Market is anticipated to be valued at USD 560.2 billion in 2024 and is further expected to reach USD 753.0 billion by 2033 , at a CAGR of 3.3%.

The Global Canned Seafood Market is expected to reach a market value of USD 35.8 billion in 2024 which is further projected to reach a value of USD 62.8 billion at a 6.4% CAGR for the forecasted period of 2024 to 2033.

The Global Granola Market is projected to be valued at USD 4,334.6 million in 2024 which is further expected to reach USD 6,657.4 million in 2032 growing at a CAGR of 4.9% rate during the forecast period.

The Global Plant-based Meat Market size is projected to reach a market value of USD 5.8 billion in 2024 which is further expected to reach USD 46.0 billion in 2023 at a CAGR of 25.8%

The Global Whiskey Market is projected to reach a market value of USD 110.7 billion in 2024 which is further expected to reach a value of USD 318.3 billion in 2032 at a CAGR of 12.5% .

The Global Organic Pet Food Market size is anticipated to be valued at USD 2.5 billion in 2024 and is further predicted to reach USD 4.8 billion by 2033, at a CAGR of 7.7 %.

The Global Ready to Drink Premixes Market is expected to reach a market value of USD 30.8 billion in 2024 which is further projected to reach a market value of USD 58.9 billion in 2033 at a CAGR of 7.5%.

The Global Meat Substitute Market is expected to reach a value of USD 28.5 billion by the end of 2024, and it is further anticipated to reach a market value of USD 751.4 billion by 2033 at a CAGR of 43.9%.

About Dimension Market Research (DMR):

Dimension Market Research (DMR) is a market research and consulting firm based in India & US, with its headquarters located in the USA (New York). The company believes in providing the best and most valuable data to its customers using the best resources analysts work, to create unmatchable insights into the industries, and markets while offering in-depth results of over 30 industries, and all major regions across the world. We also believe that our clients don't always want what they see, so we provide customized reports as well, as per their specific requirements to create the best possible outcomes for them and enhance their business through our data and insights in every possible way.

CONTACT: Contact Data Website - Email- ... Call us- +1 732 369 9777, +91 88267 74855

MENAFN28012025004107003653ID1109139264